Oxcarbazepine Suspension
Product Images NDC 72603-252

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 72603-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine-fgure1 (Oxcarbazepine Fgure1)

A Kaplan-Meier curve comparing exit rates over time from Day 2 to Day 11 between oxcarbazepine and placebo treatment groups. The plot shows higher exit rates for the placebo group compared to the oxcarbazepine group, with a log-rank test p-value of 0.0001 indicating statistically significant differences.*

FDA Label Image

Oxcarbazepine-fgure10 (Oxcarbazepine Fgure10)

Illustration showing a person opening a bottle of Oxcarbazepine oral suspension by twisting off the cap. A dropper is inserted into the bottle to indicate how to prepare the dose. The cap is placed beside the bottle.*

FDA Label Image

Oxcarbazepine-fgure11 (Oxcarbazepine Fgure11)

An illustration showing a hand holding and shaking a bottle, indicating the proper method to shake the suspension medication before use.*

FDA Label Image

Oxcarbazepine-fgure12 (Oxcarbazepine Fgure12)

An instructional illustration showing a hand holding a medication bottle with a spike top and a plunger device above it. A downward arrow indicates the plunger should be inserted into the bottle, likely depicting how to extract or mix the suspension dose.*

FDA Label Image

Oxcarbazepine-fgure13 (Oxcarbazepine Fgure13)

An instructional illustration showing a hand holding a medication bottle with a suspension syringe attached to the bottle's neck. Arrows indicate an up and down motion for drawing liquid medication into the syringe, demonstrating correct use for oral suspension dosing.*

FDA Label Image

Oxcarbazepine-fgure14 (Oxcarbazepine Fgure14)

An instructional illustration showing a hand holding an oral suspension syringe with the plunger being pulled down to measure a 10 mL dose. The syringe is attached to a bottle, indicating how to withdraw the liquid medicine accurately.*

FDA Label Image

Oxcarbazepine-fgure15 (Oxcarbazepine Fgure15)

An instructional illustration showing how to draw liquid medication from a bottle using a syringe. The image depicts hands holding a bottle and a syringe, with an arrow indicating a twisting motion to open or attach the device.*

FDA Label Image

Oxcarbazepine-fgure16 (Oxcarbazepine Fgure16)

An instructional line drawing showing a child receiving an oral medication dose via an oral syringe. Another part of the image shows a close-up of liquid being drawn from a measuring cup into the oral syringe. This illustrates the process of measuring and administering oral suspension medication.*

FDA Label Image

Oxcarbazepine-fgure2 (Oxcarbazepine Fgure2)

A Kaplan-Meier survival curve chart showing the seizure rate over time in days from the first dose to the first seizure. The chart compares two treatment groups: Oxcarbazepine and placebo, with a log-rank test p-value of 0.046, indicating statistical comparison of seizure incidence between groups.*

FDA Label Image

Oxcarbazepine-fgure3 (Oxcarbazepine Fgure3)

A Kaplan-Meier survival curve graph depicting exit rates over time (days) for two treatment groups labeled 'High' and 'Low.' The x-axis represents time to exit in days up to 130, and the y-axis shows the exit rate from 0 to 1. A p-value of 0.0001 from a log-rank test is noted above the curves.*

FDA Label Image

Oxcarbazepine-fgure4 (Oxcarbazepine Fgure4)

A Kaplan-Meier survival curve chart showing time to event (exit) on the x-axis and exit rate on the y-axis. Two treatment groups, labeled HIGH and LOW, are compared with distinct curves illustrating differences in exit rates over time. The graph includes a log-rank test with a p-value of 0.0001 indicating statistical comparison between the groups.*

FDA Label Image

Oxcarbazepine-fgure6 (Oxcarbazepine Fgure6)

Container image of OXCARBAZEPINE oral suspension, 60 mg/mL, labeled by NorthStar RxLLC. The image shows a small, round container with a flat lid, designed for the liquid medication.*

FDA Label Image

Oxcarbazepine-fgure7 (Oxcarbazepine Fgure7)

A grayscale image of an oral suspension bottle with a sealed child-resistant cap. The bottle is likely the container for Oxcarbazepine oral suspension 60 mg/mL by NorthStar RxLLC. No visible label or text is shown on the bottle in the image.*

FDA Label Image

Oxcarbazepine-fgure8 (Oxcarbazepine Fgure8)

An instructional diagram of a syringe showing labeled parts including the barrel and plunger. The syringe is depicted vertically with measurement markings visible on the barrel for liquid dosage.*

FDA Label Image

Oxcarbazepine-fgure9 (Oxcarbazepine Fgure9)

An illustration showing a hand holding and shaking an oral suspension bottle. The motion lines indicate the bottle should be shaken before use.*

FDA Label Image

Oxcarbazepine-structure (Oxcarbazepine Structure)

Chemical structure of OXCARBAZEPINE, showing its molecular framework with a dibenzazepine core and functional groups.*

FDA Label Image

Oxcarbazepinecartonlabel (Oxcarbazepinecartonlabel)

Packaging label for Oxcarbazepine Oral Suspension, USP 300 mg/5 mL, 250 mL bottle, Rx only. The label includes dosage instructions, storage conditions, and manufacturer information. Labeler is NorthStar Rx LLC, with manufacturing by Hetero Labs Limited, India. The label also features NDC 72603-252-01 and a barcode.*

FDA Label Image

Oxcarbazepinecontainerlabel (Oxcarbazepinecontainerlabel)

Label for Oxcarbazepine Oral Suspension, USP 300 mg/5 mL, in a 250 mL bottle. The label includes the NDC 72603-252-01 and states it is for prescription use only. Manufactured for Northstar Rx LLC, Memphis, TN, and by Hetero Labs Limited, Hyderabad, India. It contains storage instructions, pharmacist guidance, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.